Mercer Island, WA, United States of America

Gregory A Demopulos

This inventor holds 65 USPTO granted patents and 93 published patent applications, plus 24 CIPO patents and 22 EPO patents, primarily in Complement Activation Inhibition (CPC class A61K). Top assignees: Omeros Corporation, University of Leicester, Omeros Medical Systems, Inc.. Active years: 1998-2025.

USPTO Granted Patents = 65 

% Patents Active = 83.1

 

 

Average Co-Inventor Count = 3.2

ph-index = 21

Forward Citations = 1,517(Granted Patents)

Forward Citations (Not Self Cited) = 1,171(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Seattle, WA (US) (2015)
  • Mercer Island, WA (US) (1998 - 2024)

Company Filing History:


Years Active: 1998-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
MASP-2
Anti-Inflammatory
Ocular Solutions
PDE7 Inhibitors
Fibrosis
Angiogenesis
Graft-Versus-Host Disease
Monoclonal Antibodies
Complement Activation
Catastrophic Antiphospholipid Syndrome
Ophthalmologic Irrigation
Movement Disorders
65 patents (USPTO):Explore Patents

Title: The Innovative Journey of Gregory A. Demopulos

Introduction: Gregory A. Demopulos, a renowned inventor hailing from Mercer Island, WA (US), has made significant contributions to the field of innovations and patents.

Latest Patents: Gregory A. Demopulos holds several patents in various industries, showcasing his diverse range of expertise and creativity.

Career Highlights: With a successful career spanning decades, Gregory A. Demopulos has been at the forefront of groundbreaking inventions that have shaped industries and improved technologies worldwide.

Collaborations: Throughout his career, Gregory A. Demopulos has collaborated with leading companies, research institutions, and universities to bring his innovative ideas to life, further solidifying his reputation as a visionary inventor.

Conclusion: Gregory A. Demopulos continues to inspire with his inventive spirit and dedication to pushing the boundaries of what is possible through his remarkable contributions to the world of innovations and patents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…